Get the Stockscreener App
323.72
1.85%
-6.75
Overview
News
Price History
Option Chain
Financials
Why WST Down?
Discussions
Forecast
Stock Split
Dividend History
West Pharmaceutical Services Inc stock is traded at $323.72, with a volume of 149.91K.
It is down -1.85% in the last 24 hours and down -2.46% over the past month.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
See More
Previous Close:
$330.47
Open:
$331.46
24h Volume:
149.91K
Relative Volume:
0.32
Market Cap:
$23.97B
Revenue:
$2.88B
Net Income/Loss:
$499.60M
P/E Ratio:
48.03
EPS:
6.74
Net Cash Flow:
$321.60M
1W Performance:
-5.03%
1M Performance:
-2.46%
6M Performance:
+10.41%
1Y Performance:
-21.46%
1-Day Range:
$323.25
$332.47
1-Week Range:
$323.60
$342.55
52-Week Range:
$265.00
$413.56
West Pharmaceutical Services Inc Stock (WST) Company Profile
Name
West Pharmaceutical Services Inc
Sector
Industry
Phone
(610) 594-2900
Address
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
323.33 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
|
ISRG
Intuitive Surgical Inc
|
586.21 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
228.87 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
90.33 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
236.40 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Initiated | Citigroup | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-12-24 | Upgrade | UBS | Neutral → Buy |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jun-16-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-11-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Nov-30-22 | Initiated | UBS | Neutral |
| Oct-28-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-14-20 | Initiated | Stephens | Equal-Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-24-20 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Dec-12-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| May-01-19 | Downgrade | Jefferies | Buy → Hold |
| Apr-23-19 | Initiated | William Blair | Outperform |
| Apr-25-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-24-18 | Initiated | Goldman | Neutral |
| Oct-17-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-03-17 | Initiated | Stephens | Equal-Weight |
| Sep-15-17 | Upgrade | Jefferies | Hold → Buy |
| Oct-28-16 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Sep-21-16 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Mar-22-16 | Initiated | Wells Fargo | Outperform |
| May-14-10 | Reiterated | UBS | Neutral |
| Feb-23-10 | Initiated | Jefferies & Co | Buy |
| Dec-19-08 | Initiated | UBS | Neutral |
View All
West Pharmaceutical Services Inc Stock (WST) Latest News
Injectable Drug Device Maker West Pharma Secures Ban At ITC - Law360
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Ex-Dividend Reminder: West Pharmaceutical Services, SouthState and Pinnacle Financial Partners - Nasdaq
Pharmaceutical Packaging Market Top Companies StudyOwens - openPR
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Pharmaceutical Glass Packaging Market: Current Analysis and Forecast (2023-2030) - UnivDatos Market Insights
Trust Point Inc. Buys 2,427 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Brokerages Set West Pharmaceutical Services, Inc. (NYSE:WST) PT at $430.20 - Defense World
West Pharmaceutical Services, Inc. (NYSE:WST) Receives $430.20 Average PT from Brokerages - MarketBeat
StockNews.com Upgrades West Pharmaceutical Services (NYSE:WST) to "Buy" - MarketBeat
Swedbank AB Boosts Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Pacer Advisors Inc. Has $1.89 Million Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Conestoga Capital Advisors LLC Buys 25,110 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Declares Q1 2025 Dividend - MSN
On-Body Drug Delivery Devices Market reached US$ 40.54 billion - openPR
West Pharmaceutical Services to Announce Q4 and Full-Year 2024 Results - MSN
West Pharmaceutical Services, Inc. (NYSE:WST) to Issue Quarterly Dividend of $0.21 - MarketBeat
Tokio Marine Asset Management Co. Ltd. Raises Stake in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Fulton Breakefield Broenniman LLC Takes Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services (NYSE:WST) Raised to “Buy” at StockNews.com - Defense World
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West to Host Fourth-Quarter and Full-Year 2024 Conference Call -January 30, 2025 at 06:01 am EST - Marketscreener.com
West to Host Fourth-Quarter and Full-Year 2024 Conference Call - Finansavisen
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
West Introduces Daikyo PLASCAP RUV closures in new nested format at Pharmapack - European Pharmaceutical Manufacturer
West Pharmaceutical sets first-quarter dividend at $0.21/share By Investing.com - Investing.com Canada
West Pharmaceutical sets first-quarter dividend at $0.21/share - MSN
West Pharmaceutical Services Maintains Quarterly Dividend at $0.21 Per Share; Payable Feb. 11 to Shareholders of Record on Feb. 7 - Marketscreener.com
West Announces First-Quarter Dividend - Finansavisen
West Pharmaceutical Services (NYSE:WST) shareholders have earned a 17% CAGR over the last five years - Simply Wall St
Indo-Asian News Service-WEST ANNOUNCES FIRST-QUARTER DIVIDEND - IANS India Pvt Ltd
Vial Closure From: West Pharmaceutical Services, Inc - Healthcare Packaging
Janney Montgomery Scott LLC Makes New $14.76 Million Investment in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Atomi Financial Group Inc. Raises Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Unveils New Nested Format for Daikyo PLASCAP RUV Closures - MSN
What You Need to Know Ahead of West Pharmaceutical Services’ Earnings Release - MSN
Beacon Investment Advisory Services Inc. Sells 2,138 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors - MarketWatch
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Riverbridge Partners LLC - MarketBeat
West launches Daikyo PLASCAP RUV closures in new nested format - Packaging Gateway
West Pharmaceutical Services, Inc. Introduces Daikyo PLASCAP RUV Closures in New Nested Format At Pharmapack - Marketscreener.com
Mitsubishi UFJ Asset Management UK Ltd. Decreases Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Introduces Daikyo PLASCAP® RUV Closures in New Nested Format at Pharmapack - PR Newswire
What You Need To Know Ahead Of West Pharmaceutical Services’ Earnings Release - Barchart
West Pharmaceutical Services Inc Stock (WST) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):